24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Creativity, diversity, data visualization and plain language summaries all took centre stage at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 9–11 May 2022 in Washington, DC, USA.
Share this page As study finds that 95% of the top pharmaceutical companies worldwide aim to cut greenhouse gas emissions, commitments will require innovation and collaboration across the supply chain. Washington, DC, USA, 10 May 2022: According to a study presented at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) today, 19…
Oxford PharmaGenesis is proud to sponsor the MAPS 2022 EMEA Annual Meeting – the largest annual convention for Medical Affairs professionals in Europe, the Middle East and Africa. We are an award-winning, independent, global HealthScience consultancy. We take clients to new places with a range of transformative services. Our teams use innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.
We’re helping medical publication professionals become future-ready at the 18th Annual Meeting of ISMPP 2022. Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration and Open Pharma.
Our Informatics and Data Science team has developed a paper, in collaboration with authors from Pfizer, that details a novel approach to identifying emerging cancer biomarkers. The paper, recently published in the journal Cancer Informatics, is accompanied by a publicly accessible, interactive dashboard to allow users to explore new insights around emerging biomarkers.
Oxford PharmaGenesis is proud to sponsor the MAPS 2022 conference – the largest gathering of Medical Affairs professionals globally. We are an award-winning independent, global HealthScience communications consultancy. We take clients to new places with a range of transformative services. Our team uses innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.
